Anti-ABCG2 / BCRP Recombinant Rabbit Monoclonal Ab
克隆号:8K4
ICC IHC WB
ERB0095
货号 规格 数量. 价格 库存
ERB0095-25μg 25μg
ERB0095-100μg 100μg
ERB0095-500μg 500μg
应用
Immunocytochemistry (ICC): 1:100
Immunohistochemistry (IHC): 1:1,000
Western Blotting (WB): 1:1,000
产品信息
Reactive Species Human, Mouse
Target UniProt ID Q9UNQ0
Target Alternative Names Broad substrate specificity ATP-binding cassette transporter ABCG2, ATP-binding cassette sub-family G member 2, Breast cancer resistance protein, CDw338, Mitoxantrone resistance-associated protein, Placenta-specific ATP-binding cassette transporter, Urate exporter, CD338
Target Molecular Weight (kDa) 72 kDa
Sensitivity Endogenous
Host / lsotype Rabbit / IgG
Class Recombinant Antibody
Clone 8K4
Expression System CHO
Immunogen Recombinant protein corresponding to the N-terminal region of human BCRP.
Purification Protein A
Conjugate Unconjugated
Form Liquid
Concentration 0.5 mg/mL
Storage Buffer PBS, 40% Glycerol, 0.05% BSA, 0.04% Proclin 300
Storage Condition -20°C
背景
ABCG2, also known as Breast Cancer Resistance Protein (BCRP), is a member of the ATP-binding cassette (ABC) transporter family. It plays a key role in the efflux of a wide range of substrates, including drugs, toxins, and metabolic products, across cellular membranes. ABCG2 is widely expressed in various tissues such as the intestinal epithelium, liver, placenta, kidneys, and blood-brain barrier, where it contributes to the protection of the body by limiting the absorption of harmful compounds. In cancer cells, overexpression of ABCG2 is associated with multidrug resistance, as it can pump out chemotherapy drugs, reducing their efficacy. ABCG2 is also involved in regulating the pharmacokinetics of many therapeutic agents, making it an important target in drug development and cancer treatment strategies.
参考文献
Doyle, L.A. et al. (1998) Proc Natl Acad Sci U S A 95, 15665-70.